Brighton Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$258K Hold
223
– – 0.11% 34
2026
Q2
$267K Buy
+223
New +$228K 0.11% 33
2026
Q1
– Sell
-247
Closed -$265K – 52
2025
Q4
$265K Sell
247
-41
-14% -$39.2K 0.13% 31
2025
Q3
$220K Sell
288
-25
-8% -$18.6K 0.11% 54
2025
Q2
$244K Sell
313
-128
-29% -$99.5K 0.13% 61
2025
Q1
$364K Buy
441
+81
+23% +$67.4K 0.18% 41
2024
Q4
$278K Buy
+360
New +$298K 0.14% 52

Other funds holding LLY

Brighton Securities's LLY Position: Q3 2026 in Review

Brighton Securities held its Eli Lilly (LLY) position steady in Q3 2026 at 223 shares worth $258K. The position accounts for 0.11% of the portfolio, ranked #34.

Brighton Securities first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $364K in Q1 2025. 162 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Brighton Securities held 223 shares of Eli Lilly worth $258K as of Q3 2026.
  • Brighton Securities left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.11% of Brighton Securities's portfolio in Q3 2026, its #34 holding.
  • Brighton Securities first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Brighton Securities's Eli Lilly position peaked at $364K in Q1 2025.
  • 162 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Brighton Securities's 13F filing for Q3 2026, filed 8 Oct 2026.